By NewsDesk  @bactiman63

In a follow-up on the chikungunya outbreak in Chad, 30,220 cases have been reported since the declaration of the outbreak in August 2020.


The World Health Organization (WHO) reports cases of chikungunya are continuing to rise, with further geographical spread, although at a declining rate.

Spread from the city of Abéché, Ouaddai Province has been reported to Biltine, Wadi Fira Province and Abdi and Gozbeida, Sila Province.

One death has been reported in Kamina Health Centre, Abéché in an individual with major comorbidities.

The World Health Organization says chikungunya is an arboviral disease transmitted to humans by the bites of infected Aedes mosquitoes. The disease is characterized by an abrupt onset of fever frequently accompanied by joint pain and inflammation which is often very debilitating and may last for several months, or even years. Fatalities associated with infection can occur but are typically rare and most reported in older adults with underlying medical conditions or perinatally-infected infants. Some patients might have a relapse of rheumatologic symptoms (e.g. polyarthralgia, polyarthritis, and tenosynovitis) in the months following acute illness.

There is no specific antiviral treatment or commercially available vaccine for chikungunya.




Aedes aegypti mosquito